- JP-listed companies
- Vitabrid Japan Inc.
- Financials
- Capital expenditures
Vitabrid Japan Inc. (542A)
Market cap
¥5.6B
P/E ratio
7.6x
Vitabrid Japan makes health and beauty supplements sold directly to consumers online, with their sugar and fat-blocking supplement Terminalia First driving most sales.
| Period End | Capital expenditures (Million JPY) | YoY (%) |
|---|---|---|
| Feb 28, 2026 | -16 | -49.37% |
| Feb 28, 2025 | -32 | +21.96% |
| Feb 29, 2024 | -26 |